(MENAFN- GlobeNewsWire - Nasdaq) The Sleep Apnea Devices industry is set to grow from US$ 6.47 Billion in 2024 to an impressive US$ 12.23 Billion by 2033, at a CAGR of 7.32% from 2025 to 2033. This surge is driven by increasing sleep disorder rates, notably obstructive sleep apnea (OSA), due to factors like obesity and stress. Key growth drivers include heightened health awareness regarding untreated sleep apnea, enhanced healthcare infrastructure, and advances in sleep devices technology. The USA leads globally in market dominance, fueled by a high OSA incidence and robust health policies. Major industry players include Somnomed, ResMed, and Philips, who are innovating and expanding globally.

Dublin, Nov. 26, 2025 (GLOBE NEWSWIRE) -- The "Competitor Analysis of Sleep Apnea Devices Market Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts" report has been added to ResearchAndMarkets's offering.
The Sleep Apnea Devices industry is expected to expand lucratively to an estimated value of US$ 12.23 Billion by 2033, from US$ 6.47 Billion in 2024. This expansion reflects a compound annual growth rate (CAGR) of 7.32% between 2025 and 2033.

The rising prevalence of sleep-related disorders, particularly obstructive sleep apnea (OSA), driven by factors such as obesity, elevated stress levels, and sedentary lifestyles, is significantly fueling demand for devices like continuous positive airway pressure (CPAP) machines, masks, and oral appliances. Growing awareness about the severe health complications linked to untreated sleep apnea - such as cardiovascular disease, hypertension, and diabetes - is encouraging more individuals to pursue early diagnosis and treatment.

Furthermore, the expansion of healthcare infrastructure and the availability of advanced diagnostic sleep laboratories are contributing to market growth. Technological advancements, including the development of portable, connected, and user-friendly sleep devices, are also improving patient compliance and treatment outcomes.
The United States has emerged as a dominant region in the global sleep apnea devices market due to the rising incidence of OSA and growing health awareness. According to a 2024 study, an estimated 80.6 million Americans were projected to have OSA, comprising 47.6 million men (59%) and 33 million women (41%). The growing understanding of the health risks associated with untreated sleep disorders - such as cardiovascular disease, stroke, and diabetes - is further driving adoption of diagnostic and therapeutic devices. Additionally, favorable insurance coverage and reimbursement policies for CPAP machines, masks, and oral appliances are improving treatment accessibility and supporting sustained market expansion in the U.S.

Recent Developments of Sleep Apnea Devices Market

• One The Sleep Center of Nevada, the biggest operator of sleep clinics in the state, was finally acquired by Vivos Therapeutics in April 2025. By expanding patient reach, services, and revenue in the Las Vegas region, the USD 9 million deal aimed to increase access to Vivos' FDA-approved oral appliance therapy for OSA.
• In order to cure OSA, Fisher & Paykel Healthcare introduced the F&P Nova Nasal mask in Australia and New Zealand in March 2025. The mask's SwingFit headgear, RollFit cushion, and washable diffuser provide a snug fit, comfort, and silent operation. High user satisfaction and outstanding results were shown in clinical testing.
• In order to help patients with OSA, ResMed launched the AirSense 11 CPAP machine in India in January 2025. It featured remote updates, care check-in, and a personal therapy helper. It improved patient tracking and therapy adherence by integrating with the myAir and AirView platforms.

Key Attributes:

Report Attribute	Details
No. of Pages	200
Forecast Period	2024 - 2033
Estimated Market Value (USD) in 2024	$6.47 Billion
Forecasted Market Value (USD) by 2033	$12.23 Billion
Compound Annual Growth Rate	7.3%
Regions Covered	Global

Company Analysis

• Somnomed
• ResMed Inc.
• Koninklijke Philips N.V.
• Compumedics Limited (CMP)
• Nihon Kohden Corporation
• Natus Medical Incorporated
• Teleflex Incorporated
• Fisher & Paykel Healthcare
• Drive DeVilbiss Healthcare
• BMC Medical Co. Ltd.
• Braebon Medical Corporation
• Itamar Medical Ltd.
• Cadwell Industries, Inc.
• Invacare Corporation
• Vivos Therapeutics, Inc

Overview

• Company History and Mission
• Business Model and Operations
• Workforce

Key Persons

• Executive Leadership
• Operational Management
• Division Leaders
• Board Composition

Recent Development & Strategies

• Mergers & Acquisitions
• Partnerships
• Investments

Sustainability Analysis

• Renewable Energy Adoption
• Energy-Efficient Infrastructure
• Use of Sustainable Packaging Materials
• Water Usage and Conservation Strategies
• Waste Management and Circular Economy Initiatives

Product Analysis

• Product Profile
• Quality Standards
• Product Pipeline
• Product Benchmarking

Strategic Assessment: SWOT Analysis

• Strengths
• Weaknesses
• Opportunities
• Threats

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• Sleep Apnea Devices Market

CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN26112025004107003653ID1110399923